Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Congratulations to the 2026 Fierce AI Innovation Awards Winners
Jynneos
Pharma
Bavarian Nordic's longtime CEO Paul Chaplin to depart
Chaplin, who became CEO in 2014, said in a statement Monday that he’s stepping down because his family wants to return to Australia.
Fraiser Kansteiner
Mar 2, 2026 10:23am
Bavarian Nordic's largest shareholder objects to $3B buyout bid
Jul 28, 2025 10:31am
NIH study shows mpox shot elicits immune response in teens
Oct 17, 2024 11:17am
UNICEF taps Bavarian Nordic for 1M mpox vaccines
Sep 27, 2024 11:27am
Bavarian Nordic eyes partnerships to produce more mpox vaccines
Sep 12, 2024 12:15pm
Bavarian Nordic inks another supply deal for smallpox/mpox shot
Aug 22, 2024 2:13pm
